Advertisement
Screener

AtriCure, Inc. (ATRC) Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

AtriCure, Inc. Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High

AtriCure, Inc. (ATRC) had Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High of $260.00 million as of 2020-12-31, per its 10-K filed 2021-02-26.

Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation

us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh · last filed 2021-02-26

  • 2020-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $260.00M.
Period endBusiness Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High
2020-12-31$260.00M
10-K · filed 2021-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
Heartflow, Inc. (HTFL)United States$4.225B
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14